Steven Cohen Vanda Pharmaceuticals Inc. Transaction History

Point72 Asset Management, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$4.28 - $6.57 $246,057 - $377,709	57,490 New	57,490 $248,000
Q1 2021 May 17, 2021	SELL	$13.42 - $20.28 $2.28 Million - $3.45 Million	-170,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$9.77 - $13.81 $1.66 Million - $2.35 Million	170,000 New	170,000 $2.23 Million
Q4 2019 Feb 14, 2020	SELL	$12.38 - $17.47 $2.77 Million - $3.9 Million	-223,375 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$12.27 - $15.79 $2.74 Million - $3.53 Million	223,375 New	223,375 $2.97 Million
Q1 2018 May 15, 2018	SELL	$14.05 - $20.2 $1.76 Million - $2.53 Million	-125,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$12.85 - $18.1 $321,250 - $452,500	25,000 Added 25.0%	125,000 $1.9 Million
Q3 2017 Nov 14, 2017	BUY	$15.4 - $18.85 $1.54 Million - $1.89 Million	100,000	100,000 $1.79 Million

156

44.7M

167K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $265M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.